Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Discover how lenacapavir, a revolutionary HIV prevention tool, will be available for just $40 annually to 120 low- and middle ...

This antiretroviral has shown unprecedented results in HIV prevention, requiring only two injections per year. Its ...

Low- and middle-income countries will be able to purchase an effective preventative at a reduced price. The arrangements may ...

Generics of Gilead Sciences' twice-yearly HIV pre-exposure prophylaxis (PrEP) Yeztugo (lenacapavir) are on the horizon, with ...

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new ...

The Gates Foundation CEO Mark Suzman on Wednesday warned that child mortality is at risk of rising this year for the first ...

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.

The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...